Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VENLAFAXINE HCL, with a corresponding US DMF Number 22470.
Remarkably, this DMF maintains an Active status since its submission on January 28, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 19, 2013, and payment made on March 22, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II